EMD-52966

Single-particle
2.7 Å
EMD-52966 Deposition: 26/02/2025
Map released: 03/09/2025
Last modified: 22/10/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-52966

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-9q9s summary report (pdf.gz) Map-9q9s FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

HSV-2 prefusion glycoprotein B bound by Nb1_gbHSV

EMD-52966

Single-particle
2.7 Å
EMD-52966 Deposition: 26/02/2025
Map released: 03/09/2025
Last modified: 22/10/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Human herpesvirus 2 strain 333, Vicugna pacos
Sample: Herpes Simplex Virus 2 Glycoprotein B in complex with Nb1_gbHSV
Fitted models: 9q9s

Deposition Authors: Vollmer B , Mulvaney T , Ebel H , Nentwig J , Gruenewald K
A nanobody specific to prefusion glycoprotein B neutralizes HSV-1 and HSV-2.
Vollmer B , Ebel H , Rees R, Nentwig J , Mulvaney T , Schunemann J, Krull J, Topf M , Gorlich D, Grunewald K
(2025) Nature , 646 , 433 - 441
PUBMED: 40903574
DOI: doi:10.1038/s41586-025-09438-5
ISSN: 1476-4687
ASTM: NATUAS